# Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis

> **NCT02085395** · PHASE2 · COMPLETED · sponsor: **G&E Herbal Biotechnology Co., LTD** · enrollment: 27 (actual)

## Conditions studied

- Actinic Keratosis
- Bowen's Disease

## Interventions

- **DRUG:** SR-T100 ® Gel

## Key facts

- **NCT ID:** NCT02085395
- **Lead sponsor:** G&E Herbal Biotechnology Co., LTD
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-11
- **Primary completion:** 2010-04
- **Final completion:** 2010-11
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2014-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02085395

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02085395, "Clinical Study Assessment of SR-T100 Topical Gel Against Actinic Keratosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02085395. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*